Anupama Tewari

Anupama Tewari serves as the Associate Director at Alnylam Pharmaceuticals since January 2024. Previously, Anupama held the position of Associate Director of Clinical Operations at Sage Therapeutics from February 2021 to January 2024, overseeing clinical trial planning and execution. Anupama's experience includes roles as Associate Director of Clinical Program Operations at Reata Pharmaceuticals, Manager of Clinical Vendor Oversight at Syneos Health, Clinical Trial Project Manager at Eli Lilly and Company, and Clinical Research Associate at Roche. Anupama's career began as a Research Coordinator at Indiana University–Purdue University Indianapolis and included an early position as a Medical Technologist at DCL Medical Laboratories. Anupama holds a degree from Wichita State University and has demonstrated extensive expertise in clinical operations, team leadership, vendor management, and regulatory compliance throughout various roles in the pharmaceutical and research sectors.